Business Wire

New SailPoint SecurityIQTM Release Helps Enterprises Accelerate Compliance with Global Regulations

Del

From Navigate ’17, SailPoint, the leader in enterprise identity management, today unveiled the latest version of its data access governance solution, SecurityIQTM version 5.1. SecurityIQ allows enterprises to discover and govern access to sensitive data, enabling them to better address the growing security threat to unstructured data stored in documents and files. The latest version of SecurityIQ includes out-of-the-box compliance packs built with pre-defined policies designed to specifically address global regulatory requirements related to the General Data Protection Regulation (GDPR) and other critical compliance mandates. As a result, SecurityIQ gives enterprises the power to more confidently and efficiently address global regulations, saving enterprises both time and money while strengthening their overall security posture.

Today’s enterprises are facing increasing pressure to maintain compliance with numerous complicated regulations regarding the protection of sensitive data. Enterprises must implement policies and processes that enable them to confidently address compliance requirements without having to dedicate significant resources to develop them from the ground up. SecurityIQ 5.1 includes pre-defined policies designed specifically to support global regulations including GDPR, Personally Identifiable Information (PII) and Protected Health Information (PHI), saving enterprises weeks of policy development and expediting the process of identifying and securing sensitive data stored both on-premises and in the cloud.

“Today’s data breach landscape has thrown us into a new era of cybersecurity regulations. With data breaches making headlines every day, it’s no wonder we’re seeing complex regulatory requirements around proper governance of PII, PHI and other sensitive customer data, and steep penalties for organizations found in violation,” said Paul Trulove, SVP, SecurityIQ for SailPoint. “With SecurityIQ 5.1, we’re alleviating the burden of getting and staying compliant across some of the most widespread compliance mandates that exist today. We’re giving customers the visibility they need into all sensitive documents and files across all users and their access, regardless of where that data is stored. This not only goes a long way in addressing compliance needs, but also reduces the risk of exposure significantly by providing visibility into where sensitive data is stored, who has access to it and how they’re using it.”

New capabilities in SailPoint’s SecurityIQ 5.1 include:

  • Out-of-the-box compliance packs including pre-defined policies to address global compliance requirements, enabling organizations to accelerate readiness with GDPR, HIPAA (PHI) and PII regulatory requirements, built on SecurityIQ’s policy framework for sensitive data discovery to allow for future expansion to support other regulations.
  • Enhanced data classification engine that discovers and classifies data at enterprise-scale across both on-premises and cloud data repositories, offering petabyte scalability to support the explosive growth of unstructured data in the enterprise.
  • Enhanced data classification indexing to provide greater control of data discovery processes and added flexibility to reduce storage requirements up to ten times for index and report repositories.
  • New administrator dashboard offers clear visibility and real-time analytics, providing necessary insight to proactively identify suspicious activity, detect access violations, reduce data exposure, and take action to mitigate risk across all governed data sources.

SailPoint unveiled both SecurityIQ 5.1 and IdentityIQ 7.2 at the identity governance conference, Navigate ’17, in Amsterdam (see related release: SailPoint Propels the Identity-Aware Enterprise with New Version of IdentityIQTM). Both solutions are available today. For more information, visit: http://www.sailpoint.com.

To learn more about how SecurityIQ can help enterprises address compliance needs, please attend our webinar, Accelerate Compliance with Comprehensive Identity Governance on Wednesday, Nov. 8 at 12 p.m. (CT).

SailPoint: The Power of Identity™

SailPoint, the leader in enterprise identity management, brings the Power of Identity to customers around the world. SailPoint’s open identity platform gives organizations the power to enter new markets, scale their workforces, embrace new technologies, innovate faster and compete on a global basis. As both an industry pioneer and market leader in identity governance, SailPoint delivers security, operational efficiency and compliance to enterprises with complex IT environments. SailPoint's customers are among the world’s largest companies in a wide range of industries, including: 6 of the top 15 banks, 4 of the top 6 healthcare insurance and managed care providers, 8 of the top 15 property and casualty insurance providers, 5 of the top 15 pharmaceutical companies, and six of the largest 15 federal agencies.

Stay up-to-date on SailPoint by following us on Twitter and LinkedIn and by subscribing to the SailPoint blog.

# # #

SailPoint, the SailPoint logo, IdentityIQ, IdentityNow, IdentityAI, SecurityIQ and all techniques are trademarks or registered trademarks of SailPoint Technologies, Inc. in the U.S. and/or other countries. All other products or services are trademarks of their respective companies.

Contact information

SailPoint
Jessica Sutera, 978-278-5411
Jessica.Sutera@sailpoint.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza16.8.2018 05:00Pressemelding

BioNTech AG, a rapidly growing biotechnology company focused on precise immunotherapies for the treatment of cancer and infectious disease, today announced that it has entered into a multi-year research and development (R&D) collaboration with Pfizer Inc. (NYSE: PFE) to develop mRNA-based vaccines for prevention of influenza (flu). Under the terms of the agreement, BioNTech and Pfizer will jointly conduct research and development activities to help advance mRNA-based flu vaccines. Pfizer will assume sole responsibility for further clinical development and commercialization of mRNA-based flu vaccines, following BioNTech’s completion of a first in human clinical study. BioNTech will receive $120 million in upfront, equity and near-term research payments and up to an additional $305 million in potential development, regulatory and commercial milestone payments. In addition, BioNTech will receive up to double-digit tiered royalty payments associated with worldwide sales if the program reac

Maxion Wheels to Showcase Market-Leading Light Weight Commercial Vehicle Wheels at REIFEN 201816.8.2018 04:05Pressemelding

Maxion Wheels, the world’s largest producer of wheels, announced today its participation in REIFEN, the leading tire and wheel industry event in Europe, from Sept. 11 – 15, 2018 in Hall 12.1 / Stand D24. For the first time, REIFEN will be co-located with Automechanika Frankfurt at the Messe Frankfurt. “REIFEN is the premier event for European tire and wheel manufacturers and resellers, bringing us together to meet and collaborate on the important aftermarket themes of innovation, service and delivery,” stated Mark Gerardts, Vice President of Global Sales and Marketing, Maxion Wheels. “After a highly popular launch to truck and trailer OEMs in 2017, we’re excited to have the industry’s lightest mass production steel wheel now available to our aftermarket distributors. This wheel, along with several others, including our new 10.00W-20 wide base tubetype and tubeless heavy duty armored vehicles wheel are great examples of our continued efforts to bring our OE multi-application innovations

Lenovo Accelerates Turnaround with Back-to-Back, Double-Digit Quarterly Revenue Growth15.8.2018 23:40Pressemelding

Lenovo Group (HKSE: 0992) (PINK SHEETS: LNVGY) today announced results for its first fiscal quarter ended June 30, 2018. For the second straight quarter, Lenovo achieved strong double-digit growth in revenue year-on-year. Group revenue reached US$11.91 billion, up 19% year-on-year. The company also reported strong pre-tax income during the quarter of US$113 million, an improvement of US$182 million year-on-year, as profitability improved across all businesses. In the first fiscal quarter, Lenovo’s profit attributable to equity holders grew to US$77 million, up US$149 million year-over-year. Basic earnings per share in the first fiscal quarter was 0.65 US cents or 5.10 HK cents. “As we persistently execute our 3-wave strategy, all our businesses made solid improvements in both revenue and profitability. Lenovo has passed the turning point and entered a phase of ‘acceleration’ - accelerating the execution of our transformation strategy and accelerating the rising momentum in business per

CORRECTING and REPLACING Ebola Successfully Neutralized by Latest Generation Polyclonal Immunotherapy15.8.2018 22:37Pressemelding

Please replace the release with the following corrected version due to multiple revisions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180815005602/en/ New Ebola immunotherapy developed by SAB Biotherapeutics uses natural human polyclonal antibodies to combat disease. (Photo: SAB Biotherapeutics) The corrected release reads: EBOLA SUCCESSFULLY NEUTRALIZED BY LATEST GENERATION POLYCLONAL IMMUNOTHERAPY Promising new platform can rapidly respond to emerging infectious diseases Sioux Falls, SD, August 15, 2018 – SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided “100% protection against a lethal dose of the Ebola virus” in a recent animal study published in The Journal of Infectious Diseases . The study was conducted at the Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of He

Ebola Successfully Neutralized by Latest Generation Polyclonal Immunotherapy15.8.2018 17:43Pressemelding

SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided “100% protection against a lethal dose of the Ebola virus” in a recent animal study published in The Journal of Infectious Diseases . The study was conducted by the National Interagency Confederation for Biological Research and other collaborators including United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and the Naval Medical Research Center (NMRC). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180815005602/en/ New Ebola immunotherapy developed by SAB Biotherapeutics uses natural human polyclonal antibodies to combat disease. (Photo: SAB Biotherapeutics) According to the World Health Organization, Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe, often fatal illness in humans with an average fatality rate around 50%.

Rimini Street Receives Asia-Pacific Stevie Award for Customer Service Innovation15.8.2018 17:05Pressemelding

Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, and the leading third-party support provider for Oracle and SAP software products, today announced it has been honored with a Stevie® Award in the Innovation in Customer Service Management, Planning & Practice category for its ultra-responsive, premium level service in the Asia-Pacific region. This honor marks the Company’s 12th Stevie Award win this year, and the second consecutive year the Company has been recognized by the Asia-Pacific Stevie Awards. Rimini Street recently earned Stevie Awards in several categories, including Company of the Year from the 2018 American Business Awards® and Customer Service Department of the Year from the 2018 Stevie Awards for Sales & Customer Service. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180815005580/en/ Rimini Street Receives Asia-Pacific Stevie Award for Customer Service Innovat